Dypyridamole
CAS No. 58-32-2
Dypyridamole ( NSC 515776 | NSC 619103 )
产品货号. M15141 CAS No. 58-32-2
双嘧达莫(Persantine)是一种磷酸二酯酶抑制剂,可阻断红细胞和血管内皮细胞对腺苷的摄取和代谢。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥112 | 有现货 |
|
| 25MG | ¥157 | 有现货 |
|
| 50MG | ¥216 | 有现货 |
|
| 100MG | ¥293 | 有现货 |
|
| 500MG | ¥482 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥125 | 有现货 |
|
生物学信息
-
产品名称Dypyridamole
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述双嘧达莫(Persantine)是一种磷酸二酯酶抑制剂,可阻断红细胞和血管内皮细胞对腺苷的摄取和代谢。
-
产品描述Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.(In Vitro):Dipyridamole (5 μM; 15 min) results in a 2.5-fold increase in intracellular cAMP levels in OCI-AML-3 cells.Dipyridamole (5 μM; 48 h) with the statin combination induces apoptosis in primary AML cells.Dipyridamole (5 μM; 48 h) possesse cAMP/PKA-independent activity against statininduced SREBP2 activation.(In Vivo):Dipyridamole (10 mg/kg; p.o. once daily for 18 d) mitigates tumor growth, ameliorated concurrent alterations in blood circulation and tumor tissues, and platelet infiltration in tumor tissues.
-
体外实验Dipyridamole (5 μM; 15 min) results in a 2.5-fold increase in intracellular cAMP levels in OCI-AML-3 cells.Dipyridamole (5 μM; 48 h) with the statin combination induces apoptosis in primary AML cells.Dipyridamole (5 μM; 48 h) possesse cAMP/PKA-independent activity against statininduced SREBP2 activation. Apoptosis Analysis Cell Line:AML (OCI-AML-2, OCI-AML-3) cell line Concentration:5 μM Incubation Time:48 h Result:Induced apoptosis with the combination of fluvastatin and dipyridamole, cilostazol, forskolin, or dbcAMP in OCI-AML-2 and OCI-AML-3 cells.RT-PCRCell Line:LP1 cell line Concentration:5 μM Incubation Time:16 h Result:Increased the sensibility of cancer cells to statin-induced apoptosis.
-
体内实验Dipyridamole (10 mg/kg; p.o. once daily for 18 d) mitigates tumor growth, ameliorated concurrent alterations in blood circulation and tumor tissues, and platelet infiltration in tumor tissues. Animal Model:C57BL/6-LLC tumor-bearing mice models Dosage:10 mg/kg Administration:Oral gavage; 10 mg/kg; once daily for 18 days Result:Mitigated tumor growth in tumor-bearing mice.
-
同义词NSC 515776 | NSC 619103
-
通路Angiogenesis
-
靶点PDE
-
受体PDE| PDE
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number58-32-2
-
分子量504.63
-
分子式C24H40N8O4
-
纯度>98% (HPLC)
-
溶解度Ethanol: 50 mg/mL (99.08 mM); DMSO: 101 mg/mL (200.14 mM)
-
SMILESOCCN(CCO)C1=NC(N2CCCCC2)=C(N=C(N(CCO)CCO)N=C3N4CCCCC4)C3=N1
-
化学全称2,2',2'',2'''-((4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Fujishige K, et al. J Biol Chem. 1999 Jun 25;274(26):18438-45.
产品手册
关联产品
-
PF‐04447943
一种有效、选择性、脑渗透性、口服活性的 PDE9A 抑制剂,IC50 为 8.3 nM。
-
Cilostazol
Cilostazol (OPC 13013, OPC 21) 是一种有效的 PDE3A 抑制剂,IC50 为 0.2 uM;抑制血小板聚集,在体内具有显着的抗血栓作用。
-
Tadalafil
他达拉非是一种有效的磷酸二酯酶 5 (PDE5) 抑制剂 (IC50=1 nM)。
021-51111890
购物车()
sales@molnova.cn

